Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-07-31
1991-12-31
Doll, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 18, 530328, 530329, 530331, A61K 3700, A61K 3702, C07K 700, C07K 1500
Patent
active
050772856
ABSTRACT:
Imidazole compounds including imidazoles and imidazolium salts, and their use as transglutaminase inhibitors are disclosed.
REFERENCES:
patent: 4172139 (1979-10-01), Eakins et al.
patent: 4218476 (1980-08-01), Joensson et al.
patent: 4265898 (1981-05-01), Horstmann et al.
patent: 4487718 (1984-12-01), Aoki et al.
patent: 4868197 (1989-09-01), Schnettler et al.
Kister et al., Can. J. Chem. 57, 813 (1979).
Kister et al., Can. J. Chem. 57, 822 (1979).
Baldwin John J.
Claremon David A.
Remy David C.
Curtis Pili
Doll John
Merck & Co. , Inc.
Pfeiffer Hesna J.
Robertson Alice O.
LandOfFree
Imidazole compounds and their use as transglutaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole compounds and their use as transglutaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole compounds and their use as transglutaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1510331